Wikidata

(Q38490930)

English

Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial

scientific article published on 16 May 2011

In more languages

Statements

title
Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
21576658
retrieved
3 September 2017
author
John W. Eikelboom
object named as
John W Eikelboom
series ordinal
1
0 references
author name string
Stuart J Connolly
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
21576658
retrieved
3 September 2017
Jeff S Healey
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
21576658
retrieved
3 September 2017
Kurt Huber
series ordinal
13
1 reference
stated in
Europe PubMed Central
PubMed ID
21576658
retrieved
3 September 2017
publication date
16 May 2011
1 reference
stated in
Europe PubMed Central
PubMed ID
21576658
retrieved
3 September 2017
page(s)
2363-2372
1 reference
stated in
Europe PubMed Central
PubMed ID
21576658
retrieved
3 September 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q38490930&oldid=2113596494"